Predicting Intermediate Phenotypes in Asthma Using Bronchoalveolar Lavage-Derived Cytokines

被引:56
作者
Brasier, Allan R. [1 ,2 ,3 ]
Victor, Sundar [1 ]
Ju, Hyunsu [2 ,3 ]
Busse, William W. [4 ]
Curran-Everett, Douglas [5 ]
Bleecker, Eugene [6 ]
Castro, Mario [7 ]
Chung, Kian Fan [8 ]
Gaston, Benjamin [9 ]
Israel, Elliot [10 ]
Wenzel, Sally E. [11 ]
Erzurum, Serpil C. [12 ]
Jarjour, Nizar N. [4 ]
Calhoun, William J. [1 ,2 ,3 ]
机构
[1] Univ Texas Med Branch UTMB, Sealy Ctr Mol Med, Galveston, TX USA
[2] UTMB, Dept Internal Med, Galveston, TX USA
[3] UTMB, Inst Translat Sci, Galveston, TX USA
[4] Univ Wisconsin, Dept Med, Madison, WI USA
[5] Natl Jewish Hlth, Denver, CO USA
[6] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
[7] Washington Univ, Dept Med, St Louis, MO USA
[8] Univ London Imperial Coll Sci Technol & Med, London, England
[9] Univ Virginia, Charlottesville, VA USA
[10] Brigham & Womens Hosp, Boston, MA 02115 USA
[11] Univ Pittsburgh, Pittsburgh, PA USA
[12] Cleveland Clin, Cleveland, OH 44106 USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2010年 / 3卷 / 04期
关键词
asthma; logistic regression; multivariate regression splines; quantitative phenotypes; personalized medicine; NEUTROPHILIC INFLAMMATION; INHALED CORTICOSTEROIDS; BIOMARKER DISCOVERY; SPUTUM; LUNG; VALIDATION; MODERATE; COUNTS; ADULTS; COSTS;
D O I
10.1111/j.1752-8062.2010.00204.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An important problem in realizing personalized medicine is the development of methods for identifying disease subtypes using quantitative proteomics. Recently we found that bronchoalveolar lavage (BAL) cytokine patterns contain information about dynamic lung responsiveness. In this study, we examined physiological data from 1,048 subjects enrolled in the US Severe Asthma Research Program (SARP) to identify four largely separable, quantitative intermediate phenotypes. Upper extremes in the study population were identified for eosinophil-or neutrophil-predominant inflammation, bronchodilation in response to albuterol treatment, or methacholine sensitivity. We evaluated four different statistical ("machine") learning methods to predict each intermediate phenotype using BAL cytokine measurements on a 76 subject subset. Comparison of these models using area under the ROC curve and overall classification accuracy indicated that logistic regression and multivariate adaptive regression splines produced the most accurate methods to predict intermediate asthma phenotypes. These robust classification methods will aid future translational studies in asthma targeted at specific intermediate phenotypes. Clin Trans Sci 2010; Volume 3: 147-157
引用
收藏
页码:147 / 157
页数:11
相关论文
共 50 条
  • [31] Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation
    Miranda, C
    Busacker, A
    Balzar, S
    Trudeau, J
    Wenzel, SE
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) : 101 - 108
  • [32] Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
    Moore, Wendy C.
    Bleecker, Eugene R.
    Curran-Everett, Douglas
    Erzurum, Serpil C.
    Ameredes, Bill T.
    Bacharier, Leonard
    Calhoun, William J.
    Castro, Mario
    Chung, Kian Fan
    Clark, Melissa P.
    Dweik, Raed A.
    Fitzpatrick, Anne M.
    Gaston, Benjamin
    Hew, Mark
    Hussain, Iftikhar
    Jarjour, Nizar N.
    Israel, Elliot
    Levy, Bruce D.
    Murphy, James R.
    Peters, Stephen P.
    Teague, W. Gerald
    Meyers, Deborah A.
    Busse, William W.
    Wenzel, Sally E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (02) : 405 - 413
  • [33] Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
    Nair, Parameswaran
    Pizzichini, Marcia M. M.
    Kjarsgaard, Melanie
    Inman, Mark D.
    Efthimiadis, Ann
    Pizzichini, Emilio
    Hargreave, Frederick E.
    O'Byrne, Paul M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) : 985 - 993
  • [34] Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation
    Pazdrak, Konrad
    Young, Travis W.
    Stafford, Susan
    Olszewska-Pazdrak, Barbara
    Straub, Christof
    Starosta, Vitaliy
    Brasier, Allan
    Kurosky, Alexander
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (06) : 4182 - 4190
  • [35] The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts
    Puxeddu, I
    Bader, R
    Piliponsky, AM
    Reich, R
    Levi-Schaffer, F
    Berkman, N
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) : 103 - 110
  • [36] Protein biomarker discovery and validation: the long and uncertain path to clinical utility
    Rifai, Nader
    Gillette, Michael A.
    Carr, Steven A.
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (08) : 971 - 983
  • [37] Biomarker discovery and validation
    Rifai, Nader
    Gerszten, Robert E.
    [J]. CLINICAL CHEMISTRY, 2006, 52 (09) : 1635 - 1637
  • [38] Costs of asthma according to the degree of severity
    Serra-Batlles, J
    Plaza, V
    Morejón, E
    Comella, A
    Brugués, J
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (06) : 1322 - 1326
  • [39] Differences in airway cytokine profile in severe asthma compared to moderate asthma
    Shannon, Joanne
    Ernst, Pierre
    Yamauchi, Yasuhiro
    Olivenstein, Ronald
    Lemiere, Catherine
    Foley, Susan
    Cicora, Leo
    Ludwig, Mara
    Hamid, Qtttayba
    Martin, James G.
    [J]. CHEST, 2008, 133 (02) : 420 - 426
  • [40] ASYMPTOTIC EQUIVALENCE OF CHOICE OF MODEL BY CROSS-VALIDATION AND AKAIKES CRITERION
    STONE, M
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1977, 39 (01) : 44 - 47